Sökning: onr:"swepub:oai:lup.lub.lu.se:c76589e1-2b48-4bcf-8224-d773777ad56b" >
Antithrombotic ther...
-
Batra, GoravUppsala universitet,Uppsala University,Kardiologi,Uppsala kliniska forskningscentrum (UCR)
(författare)
Antithrombotic therapy after myocardial infarction in patients with atrial fibrillation undergoing percutaneous coronary intervention
- Artikel/kapitelEngelska2018
Förlag, utgivningsår, omfång ...
-
2017-11-06
-
Oxford University Press (OUP),2018
-
10 s.
Nummerbeteckningar
-
LIBRIS-ID:oai:lup.lub.lu.se:c76589e1-2b48-4bcf-8224-d773777ad56b
-
https://lup.lub.lu.se/record/c76589e1-2b48-4bcf-8224-d773777ad56bURI
-
https://doi.org/10.1093/ehjcvp/pvx033DOI
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-320310URI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:139748155URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:art swepub-publicationtype
-
Ämneskategori:ref swepub-contenttype
Anmärkningar
-
Aims Optimal antithrombotic therapy after percutaneous coronary intervention (PCI) in patients with myocardial infarction (MI) and atrial fibrillation is uncertain. In this study, we compared antithrombotic regimes with regard to a composite cardiovascular outcome of all-cause mortality, MI or ischaemic stroke, and major bleeds. Methods and results Patients between October 2005 and December 2012 were identified in Swedish registries, n = 7116. Landmark 0-90 and 91-365 days of outcome were evaluated with Cox-regressions, with dual antiplatelet therapy as reference. At discharge, 16.2% received triple therapy (aspirin, clopidogrel, and warfarin), 1.9% aspirin plus warfarin, 7.3% clopidogrel plus warfarin, and 60.8% dual antiplatelets. For cardiovascular outcome, adjusted hazard ratio with 95% confidence interval (HR) for triple therapy was 0.86 (0.70-1.07) for 0-90 days and 0.78 (0.58-1.05) for 91-365 days. A HR of 2.16 (1.48-3.13) and 1.61 (0.98-2.66) during 0-90 and 91-365 days, respectively, was observed for major bleeds. For aspirin plus warfarin, HR 0.82 (0.54-1.26) and 0.62 (0.48-0.79) was observed for cardiovascular outcome and 1.30 (0.60-2.85) and 1.01 (0.63-1.62) for major bleeds during 0-90 and 91-365 days, respectively. For clopidogrel plus warfarin, HR of 0.90 (0.68-1.19) and 0.68 (0.49-0.95) was observed for cardiovascular outcome and 1.28 (0.71-2.32) and 1.08 (0.57-2.04) for major bleeds during 0-90 and 91-365 days, respectively. Conclusion Compared to dual antiplatelets, aspirin or clopidogrel plus warfarin therapy was associated with similar 0-90 days and lower 91-365 days of risk of the cardiovascular outcome, without higher risk of major bleeds. Triple therapy was associated with non-significant lower risk of cardiovascular outcome and higher risk of major bleeds.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Friberg, LeifKarolinska Institutet,Karolinska Institute
(författare)
-
Erlinge, DavidLund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Skåne University Hospital(Swepub:lu)kard-der
(författare)
-
James, Stefan K,1964-Uppsala universitet,Uppsala University,Kardiologi,Uppsala kliniska forskningscentrum (UCR)(Swepub:uu)stjam367
(författare)
-
Jernberg, TomasKarolinska Institutet,Karolinska Institute,Karolinska University Hospital
(författare)
-
Svennblad, BodilUppsala universitet,Uppsala University,Uppsala University Hospital,Uppsala kliniska forskningscentrum (UCR),Ortopedi(Swepub:uu)bosve677
(författare)
-
Wallentin, Lars,1943-Uppsala universitet,Uppsala University,Kardiologi,Uppsala kliniska forskningscentrum (UCR)(Swepub:uu)larswall
(författare)
-
Oldgren, Jonas,1964-Uppsala universitet,Uppsala University,Kardiologi,Uppsala kliniska forskningscentrum (UCR)(Swepub:uu)jonaoldg
(författare)
-
Uppsala UniversityKardiologi
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:European Heart Journal - Cardiovascular Pharmacotherapy: Oxford University Press (OUP)4:1, s. 36-452055-68372055-6845
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Batra, Gorav
-
Friberg, Leif
-
Erlinge, David
-
James, Stefan K, ...
-
Jernberg, Tomas
-
Svennblad, Bodil
-
visa fler...
-
Wallentin, Lars, ...
-
Oldgren, Jonas, ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
- Artiklar i publikationen
-
European Heart J ...
- Av lärosätet
-
Lunds universitet
-
Uppsala universitet
-
Karolinska Institutet